It has not taken long for private enquiry firms to circle Healthia (ASX: HLA), Australia fastest growing physiotherapy and podiatry operator which has received an offer to be 100% acquired for $260 million. The binding Scheme Implementation Deed comes from Harold BidCo, an entity owned by funds advised by Pacific Equity Partners (PEP) at $1.80
Read More
Having announced the acquisition of The Optical Company and its 41 optometry clinics, Healthia (ASX: HLA) Chairman Glen Richards and CEO Wesley Coote caught up with Emerald Financial’s Bronte Moore to discuss the allied healthcare market and Healthia’s rapidly growing network. Click below to watch the update. Investors can keep up to date with Healthia
Read More
Allied healthcare provider Healthia (ASX: HLA) has reported a 40.3% increase in revenues where business has returned to pre-COVID levels, with clinics having remained open through the pandemic in order to take pressure off the public health system as per Government directives. Alongside the jump in revenue for FY20 to $92.4m, Healthia has also reported
Read More
National healthcare provider Healthia Ltd (ASX: HLA) has released its maiden FY earnings report with the Company delivering pro-forma EBITDA of $11.7 million*, exceeding forecasts by 13.6%. Since listing on the ASX in September 2018 under the guidance of Chairman Glen Richards, Healthia has increased their national presence through the continued acquisition of allied health
Read More